This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Illinois Tool Works (ITW) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Illinois Tool Works (ITW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Dover Corporation (DOV) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Dover Corporation (DOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Dover (DOV) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Dover's (DOV) fourth-quarter results are expected to reflect the benefits of strong order trends across segments, backed by strong demand and margin improvement actions.
Lindsay (LNN) Tops Q1 Earnings Estimates
by Zacks Equity Research
Lindsay (LNN) delivered earnings and revenue surprises of 32% and 1.41%, respectively, for the quarter ended November 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Is Idex (IEX) Up 7.1% Since Last Earnings Report?
by Zacks Equity Research
Idex (IEX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Dover (DOV) Earnings Beat Estimates in Q3, Lowers FY22 View
by Zacks Equity Research
Dover's (DOV) Q3 results gains on strong demand and robust backlog levels as well as improving price-cost dynamics.
Dover Corporation (DOV) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Dover Corporation (DOV) delivered earnings and revenue surprises of 2.73% and 0.08%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Idex (IEX) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Idex (IEX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Dover (DOV) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Dover's (DOV) Q3 performance is likely to have benefited from the solid order trends across segments, driven by strong demand and margin-improvement actions.
Dover Corporation (DOV) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Dover Corporation (DOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DOV vs. NDSN: Which Stock Is the Better Value Option?
by Zacks Equity Research
DOV vs. NDSN: Which Stock Is the Better Value Option?
DOV or IEX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
DOV vs. IEX: Which Stock Is the Better Value Option?
Dover's (DOV) Arm Inks Deal to Offer Complete Fuel Solutions
by Zacks Equity Research
Dover (DOV) business unit DFS's latest partnership with Bottomline will provide combined fuel management solution to customers that can save retailers' costs by 5-10% through automated operations.
Is Dover (DOV) a Suitable Stock for Value Investors?
by Zacks Equity Research
Is Dover (DOV) a great pick from the value investor's perspective right now? Read on to know more.
Here's Why Investors Should Retain Dover (DOV) Stock For Now
by Zacks Equity Research
Dover (DOV) is benefiting from solid order trends, strong demand across end markets and cost-control actions despite supply chain challenges and escalating costs.
Dover (DOV) Earnings Beat Estimates in Q2, Sales Up Y/Y
by Zacks Equity Research
Dover's (DOV) Q2 top line benefits from strong demand and robust backlog levels.
Dover Corporation (DOV) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Dover Corporation (DOV) delivered earnings and revenue surprises of 2.88% and 0.71%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Idex (IEX) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Idex (IEX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Dover (DOV) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Dover's (DOV) Q2 performance is likely to have benefited from the solid order trends across segments, stemming from strong demand and margin-improvement actions.
Dover Corporation (DOV) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Dover Corporation (DOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Dover (DOV) Rides on Strong Demand & Buyouts Amid High Costs
by Zacks Equity Research
Dover (DOV) is benefiting from strong demand across end markets, strategic acquisitions and cost-control actions despite supply chain challenges and escalating costs.
Dover (DOV) Closes Malema Buyout, Boosts Biopharma Portfolio
by Zacks Equity Research
Dover (DOV) is working toward building its biopharma platform through new product developments and opportunistic acquisitions, with the Malema buyout being the latest.
Lindsay (LNN) to Report Q3 Results: What's in the Cards?
by Zacks Equity Research
Lindsay's (LNN) Q3 performance is likely to reflect benefits from increased demand for irrigation equipment and transportation safety products.
Apogee (APOG) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Apogee's (APOG) Q1 performance will likely benefit from strong order levels, pricing actions and productivity improvement efforts.
Xylem (XYL) Up 0.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Xylem (XYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.